Curexo Inc. (KOSDAQ:060280)
South Korea · Delayed Price · Currency is KRW 13,800
+770 (5.91%)
At close: Dec 9, 2025
Curexo Market Cap
Curexo has a market cap or net worth of 567.04 billion as of December 10, 2025. Its market cap has increased by 121.15% in one year.
Market Cap
567.04B
Enterprise Value
542.62B
Revenue
27.85B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,800.00
Market Cap Chart
Since November 3, 2004, Curexo's market cap has increased from 3.98B to 567.04B, an increase of 14,138.34%. That is a compound annual growth rate of 26.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 567.04B | 113.62% |
| Dec 30, 2024 | 265.44B | -65.17% |
| Dec 28, 2023 | 762.19B | 191.52% |
| Dec 29, 2022 | 261.46B | 5.49% |
| Dec 30, 2021 | 247.86B | 18.34% |
| Dec 30, 2020 | 209.44B | 32.32% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.76T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.65T |